1800 244 735

Helpline (02) 9874 9777

Therapeutics conference videos now online

HDBuzz covered CHDI’s therapeutics conference in February 2011 from Palm Springs. Now, videos of many of the scientific presentations have been made available to watch online.

The therapeutics conference

The annual Huntington’s disease Therapeutics Conference, hosted by CHDI Foundation Inc., is a unique forum for HD researchers to come together, share exciting findings, and establish collaborations and partnerships that accelerate the pace of research into therapies for Huntington’s disease.

CHDI is a not-for-profit ‘virtual biotechnology company’ that aims to “rapidly discover and develop drugs that delay or slow Huntington’s Disease”. It’s the largest single driving force behind the development HD treatments.

Shortly after HDBuzz launched in January, we reported from the 2011 Therapeutics Conference, held in Palm Springs, California. Our daily reports from the conference gave a plain-language overview of all the main science presented at the conference – and it was a ton of exciting stuff!

You can find our reports by searching for ‘CHDI’ on HDBuzz.net.

The videos

For the first time, videos of many of the scientific presentations have now been made available online. To find them, visit http://chdifoundation.org/ and click the ‘Presentations from the 2011 HD Therapeutics Conference’ link.

Be prepared, though: these presentations were delivered by scientists, to a room full of scientists – so they’re all rather more intensive than a typical HDBuzz article!

So, you might find helpful to consult our daily conference reports, alongside the videos.

We applaud this move – it was an exciting conference and the science deserves to reach as many people as possible. As far as HDBuzz is concerned, making conference presentations available online like this is a great step forward.

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Scientists identify precisely how pridopidine works in models of Huntington’s disease

Published date: 12 June, 2021

Pridopidine is a drug developed to treat Huntington’s disease (HD) and now scientists have a clearer understanding of how it works in the body and brain. In a series of academic papers, researchers figured out that pridopidine is working by targeting a particular receptor protein called S1R. With this new understanding, the researchers believe pridopidine ... Read more

Huntington's disease therapeutics conference 2021 – Day 3

Published date: 29 April, 2021

We are back for the last day of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can find with the hashtag #HDTC2021. The final session of the conference will provide the latest news on more Huntington’s disease clinical programs. A new way ... Read more

Huntington's disease therapeutics conference 2021 – Day 2

Published date: 28 April, 2021

We are back with Day 2 of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning session focussed on promising HD therapeutics that are in preclinical development and the afternoon session covered different ... Read more

Huntington’s disease therapeutics conference 2021 – Day 1

Published date: 28 April, 2021

The CHDI Therapeutics Conference 2021 kicked off today. This article summarizes our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning of Day 1 focused on clinical trial updates, while the afternoon explored genetic modifiers of HD and how they might be harnessed ... Read more

Huntington’s disease clinical trial round up

Published date: 26 April, 2021

It seems like the HD community has been inundated with updates from different companies and clinical trials recently. The news is far from complete doom and gloom; although there have been some real disappointments from some of the frontrunner trials, there are also positive updates from many different companies and lots of reasons for us ... Read more

Good news from uniQure: gene therapy trial on track, and promising data in animals

Published date: 15 April, 2021

Two recent press releases from uniQure provide welcome good news: the first ever HD gene therapy, known as AMT-130, has been administered via brain surgery to a small set of participants in an early safety trial. At the same time, uniQure has published findings in HD animal models that increase confidence in the drug’s ability ... Read more